Anti-amyloid drug shows signs of preventing Alzheimer’s dementia

An experimental drug appears to reduce the risk of Alzheimer’s-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a study led by the Knight Family Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), which is based at Washington University School of Medicine in St. Louis.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup